tepoditamab   Click here for help

GtoPdb Ligand ID: 10353

Synonyms: MCLA-117 | MCLA117 | PB9122
Immunopharmacology Ligand
Compound class: Antibody
Comment: Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds CLEC12A on myeloid cells and CD3ε on cytotoxic T cells. It is being developed by Merus as a novel therapy for acute myeloid leukemia (AML) [1].
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10766 tepoditamab
Synonyms Click here for help
MCLA-117 | MCLA117 | PB9122
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 812
Other databases
GtoPdb PubChem SID 384403634
Search PubMed clinical trials tepoditamab
Search PubMed titles tepoditamab
Search PubMed titles/abstracts tepoditamab